Transfusion of Fresh Frozen Plasma in Critically Ill Patients: Effective or Useless?
DOI:
https://doi.org/10.3889/oamjms.2018.212Keywords:
Fresh frozen plasma, Transfusion, Increased INR, Invasive procedureAbstract
BACKGROUND: Fresh frozen plasma (FFP) is widely used in critically ill patients to correct the deficiency of coagulation factors or increased INR.
AIM: In the present study we aimed to evaluate the outcome of the freshly frozen plasma use as prophylaxis in ICU patients before an invasive procedure.
METHODS: The study was conducted at Central Anaesthesiology and Intensive Care Service UHCT “Mother Theresaâ€, Tirana. 136 patients were enrolled with coagulopathy with no bleeding before the invasive procedure, from June 2016 to December 2016. A group of 75 patients underwent a median volume of 12.5 ml/kg FFP given, and 61 had no transfusion. Data were collected on demographics, the severity of illness measured by APACHE III scores, INR, medication use, hemodynamic data.
RESULTS: From 136 patients with coagulopathy with no bleeding who underwent planned invasive interventions, 75 [55%] received FFP, vs 61 [45%] p = 0.04 who did not receive. Overall, the median FFP dose was 12.5 ml kg-1. Median INR level in FFP and non-FFP groups was respectively 3.1 (1.9-4.8) and 3.5 (1.8-5.2). INR was corrected in 24 of 75 (32%) of those who received a transfusion. The frequency of minor bleeding episodes was 9.3% in transfused patients vs 4.9% in the non-transfused group. Patients who developed an onset of acute lung injury were more frequent in the FFP group. No allergic transfusion complications were observed. Also, the median length of hospital stay [LOS] was 3.05 days vs 2.91 days and mortality rate 8.2% vs 6.5% with no significant difference between two groups.
CONCLUSIONS: Freshly frozen plasma transfusions are often unnecessarily administered during an inadequate correction of the deficiencies of coagulation factors. When comparing a liberal FFP transfusion strategy vs restrictive other clinical trials are required to asses which one is the best to adopt in intensive care settings.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Fresh frozen plasma: Indications and risks. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement. 1984; 5(5):4. PMid:6395009
Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D. Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care. 2011; 15(2):R108. https://doi.org/10.1186/cc10129 PMid:21466676 PMCid:PMC3219386
Tinmouth AT, McIntyre L. The conundrum of persistent inappropriate use of frozen plasma. Crit Care. 2011; 15(3):160. https://doi.org/10.1186/cc10215 PMid:21635704 PMCid:PMC3218970
O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004; 126(1):11-28. https://doi.org/10.1111/j.1365-2141.2004.04972.x PMid:15198728
Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004; 126(1):139-52. https://doi.org/10.1111/j.1365-2141.2004.04973.x PMid:15198745
Holland L, Sarode R. Should plasma be transfused prophylactically before invasive procedures? Curr Opin Hematol. 2006; 13(6):447-51. https://doi.org/10.1097/01.moh.0000245688.47333.b6 PMid:17053457
Walker RH. Special report: Transfusion risks. Am J Clin Path. 1987; 88:374-8. https://doi.org/10.1093/ajcp/88.3.374 PMid:3630978
Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006; 46(8):1279-85. https://doi.org/10.1111/j.1537-2995.2006.00891.x PMid:16934060
Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006; 126(1):133-9. https://doi.org/10.1309/NQXHUG7HND78LFFK
Green L, Cardigan R, Beattie C, Bolton-Maggs P, Stanworth SJ, Thachil J, Kallis Y, Zahra S. Addendum to the British Committee for Standards in Haematology (BCSH): Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11-28). Br J Haematol. 2017; 178(4):646-647. https://doi.org/10.1111/bjh.14163 PMid:27306832
Doerfler ME, Kaufman B, Goldenberg AS. Central venous catheter placement in patients with disorders of hemostasis. Chest. 1996; 110(1):185-8. https://doi.org/10.1378/chest.110.1.185 PMid:8681626
Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets: Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA. 1994; 271(10):777-81. https://doi.org/10.1001/jama.1994.03510340067036
Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004; 125(1):69-73. https://doi.org/10.1111/j.1365-2141.2004.04868.x PMid:15015971
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0